Keros Therapeutics (KROS) PT Lowered to $18 at Wells Fargo
Wells Fargo analyst Ben Burnett ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)